<p class="title">New India Assurance Company on Tuesday launched a comprehensive world-wide mediclaim policy named 'New India Global Mediclaim Policy.' The policy will cover an insured's hospitalisation expenses for treatments like cancer, neurosurgery, heart surgery, organ transplant and bone marrow transplant in hospitals outside India.</p>.<p class="bodytext">New India Global Mediclaim is a Critical Illness product with two major plans, one covering hospitalisation with medical centres in Asian countries while the second plan offers the same service, worldwide. </p>.<p class="bodytext">The Asian countries medical coverage plan offers a lifetime cover of $1 million and the worldwide lifetime coverage insures an individual for $2 million. </p>.<p class="bodytext">The policy covers an entire gamut of services like medical second opinion for the covered illness of the insured to the expenses like travel, accommodation and treatment in a foreign land, a company release said.</p>.<p class="bodytext">G Srinivasan, Chairman and Managing Director, New India Assurance said, "Global Mediclaim policy has been designed to ensure that Indians will now get a choice to pursue the best medical treatment available anywhere in the world with a comprehensive insurance cover from an Indian insurer. Global Mediclaim Policy is a new milestone in Indian health insurance industry."</p>.<p class="bodytext">The entry age of Global Mediclaim Policy is between 18-65 years and will be issued only to Indian citizens residing in India. </p>.<p class="bodytext">The product is available to any person who already has a health insurance policy with sum insured of Rs 8 lakh and above. Global medical centres like Cedar-Sinai Medical Center, John Hopkins Medical Center and Kings College Hospital are among the 99 top notch hospitals worldwide who are a part of New India's empanelled hospitals.</p>.<p class="bodytext">The company, for the nine months ended December 31, 2017, has clocked a profit after tax of Rs 1,865 crore. The Asset base of the company has crossed Rs 78,000 crore. </p>
<p class="title">New India Assurance Company on Tuesday launched a comprehensive world-wide mediclaim policy named 'New India Global Mediclaim Policy.' The policy will cover an insured's hospitalisation expenses for treatments like cancer, neurosurgery, heart surgery, organ transplant and bone marrow transplant in hospitals outside India.</p>.<p class="bodytext">New India Global Mediclaim is a Critical Illness product with two major plans, one covering hospitalisation with medical centres in Asian countries while the second plan offers the same service, worldwide. </p>.<p class="bodytext">The Asian countries medical coverage plan offers a lifetime cover of $1 million and the worldwide lifetime coverage insures an individual for $2 million. </p>.<p class="bodytext">The policy covers an entire gamut of services like medical second opinion for the covered illness of the insured to the expenses like travel, accommodation and treatment in a foreign land, a company release said.</p>.<p class="bodytext">G Srinivasan, Chairman and Managing Director, New India Assurance said, "Global Mediclaim policy has been designed to ensure that Indians will now get a choice to pursue the best medical treatment available anywhere in the world with a comprehensive insurance cover from an Indian insurer. Global Mediclaim Policy is a new milestone in Indian health insurance industry."</p>.<p class="bodytext">The entry age of Global Mediclaim Policy is between 18-65 years and will be issued only to Indian citizens residing in India. </p>.<p class="bodytext">The product is available to any person who already has a health insurance policy with sum insured of Rs 8 lakh and above. Global medical centres like Cedar-Sinai Medical Center, John Hopkins Medical Center and Kings College Hospital are among the 99 top notch hospitals worldwide who are a part of New India's empanelled hospitals.</p>.<p class="bodytext">The company, for the nine months ended December 31, 2017, has clocked a profit after tax of Rs 1,865 crore. The Asset base of the company has crossed Rs 78,000 crore. </p>
